| Placental-derived mesenchyme influences chorionic gonadotropin and progesterone secretion of human embryonic stem cell-derived trophoblasts. | |
| | |
MedLine Citation:
|
PMID: 20601539 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Studies of early placental development in humans are difficult because of limitations on experimental material availability from the perimplantation period. We used a coculture system to determine the effects of various effector cell types on trophoblast differentiation. Enhanced green fluorescent protein (EGFP)-expressing H1 human embryonic stem cells were used in co-suspension with human term placental fibroblasts (TPFs) and dermal fibroblasts (CI2F) to form combination embryoid bodies (EBs), with the goal of recapitulating placental morphogenesis through incorporation of placental mesenchymal cells. Overall, the results demonstrated that when using mesenchymal cells for EB preparation from term placentas (TPF), combination EB-derived trophoblasts secrete higher levels of human chorionic gonadotropin (hCG) and progesterone compared to EBs made without effector cells, whereas there was no effect of dermal fibroblasts. This is due to the secretory activity of the EB-derived trophoblasts and not due to the number of differentiated trophoblasts per EB, demonstrating that nontrophoblast cells of the placenta can influence trophoblast endocrine activity. |
| | |
Authors:
|
Maria Giakoumopoulos; Leah M Siegfried; Svetlana V Dambaeva; Mark A Garthwaite; M Clay Glennon; Thaddeus G Golos |
Related Documents
:
|
738279 - Complexity of polysomal polyadenylated rna in undifferentiated and differentiated neuro... 2069569 - A novel brain-specific mrna encoding nuclear protein (necdin) expressed in neurally dif... 18085819 - Animal cell differentiation patterns suppress somatic evolution. 15572029 - Gdnf-induced leukemia inhibitory factor can mediate differentiation via the mek/erk pat... 7498169 - Analysis of proteins from human breast epithelial cells using two-dimensional gel elect... 16755039 - Efficient gene transfer into differentiated human trophoblast cells with adenovirus vec... 18454669 - Bone augmentation with autologous periosteal cells and two different calcium phosphate ... 15975089 - Slx4 becomes phosphorylated after dna damage in a mec1/tel1-dependent manner and is req... 2104849 - Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured br... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2010-07-02 |
Journal Detail:
|
Title: Reproductive sciences (Thousand Oaks, Calif.) Volume: 17 ISSN: 1933-7205 ISO Abbreviation: Reprod Sci Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-11 Completed Date: 2010-11-22 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 101291249 Medline TA: Reprod Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 798-808 Citation Subset: IM |
Affiliation:
|
Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Communication* Cell Differentiation* Cells, Cultured Chorionic Gonadotropin / secretion* Coculture Techniques Embryonic Stem Cells / secretion* Female Fibroblasts* / metabolism Green Fluorescent Proteins / biosynthesis, genetics Humans Immunohistochemistry Mesoderm / cytology*, metabolism Placenta / cytology*, metabolism Pregnancy Progesterone / secretion* Time Factors Transfection Trophoblasts / secretion* |
| Grant Support | |
ID/Acronym/Agency:
|
C06 RR015459-01/RR/NCRR NIH HHS; C06 RR020141-01/RR/NCRR NIH HHS; HD T32 041921/HD/NICHD NIH HHS; HD038843/HD/NICHD NIH HHS; HD046919/HD/NICHD NIH HHS; P01 HD038843-07/HD/NICHD NIH HHS; P01 HD038843-08/HD/NICHD NIH HHS; P01 HD038843-09/HD/NICHD NIH HHS; P01 HD038843-10/HD/NICHD NIH HHS; P51 RR000167/RR/NCRR NIH HHS; P51 RR000167-41/RR/NCRR NIH HHS; P51 RR000167-42/RR/NCRR NIH HHS; P51 RR000167-43/RR/NCRR NIH HHS; P51 RR000167-44/RR/NCRR NIH HHS; P51 RR000167-45/RR/NCRR NIH HHS; P51 RR000167-46/RR/NCRR NIH HHS; P51 RR000167-48/RR/NCRR NIH HHS; P51 RR000167-49/RR/NCRR NIH HHS; P51 RR000167-50/RR/NCRR NIH HHS; R21 HD046919-01A2/HD/NICHD NIH HHS; R21 HD046919-02/HD/NICHD NIH HHS; RR020141-01/RR/NCRR NIH HHS; RR15459-01/RR/NCRR NIH HHS; T32 HD041921-06/HD/NICHD NIH HHS; T32 HD041921-07/HD/NICHD NIH HHS; T32 HD041921-08/HD/NICHD NIH HHS; UL1 RR025011/RR/NCRR NIH HHS; UL1 RR025011-01/RR/NCRR NIH HHS; UL1 RR025011-02/RR/NCRR NIH HHS; UL1 RR025011-03/RR/NCRR NIH HHS; UL1 RR025011-04/RR/NCRR NIH HHS; UL1 RR025011-05/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Chorionic Gonadotropin; 0/enhanced green fluorescent protein; 147336-22-9/Green Fluorescent Proteins; 57-83-0/Progesterone |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Polymorphisms of human nonmetastatic clone 23 type 1 gene and neoplastic lesions of uterine cervix.
Next Document: Maternal and fetal thrombophilia in intrauterine growth restriction in the presence or absence of ma...